For Thinning Hair - Medium Dilution Stage.
Male Composition. For 2 Months.

Activates The Normal Growth Of Hair In Areas With Thinning.
Effective In 100% Of Individuals Tested.
With Active Ingredients Of Transdermal Technology.

Crescina Growth Is A Topical Dermo-Cosmetic Treatment Focused On The Treatment Of Thinning Hair, Which Activates The Normal Growth Of Hair And Is Not Another Anti-Hair Loss Product In Order To Slow Down Or Prevent The Detachment Of Existing Hair. On The Scalp.
It Is Designed To Prevent And Treat Thinning Caused By Normal (Non-Pathological) Causes And For Cases Where The Quantity And Quality Of Hair Is Gradually Reduced Due To The Reduced Activity Of Hair Follicles.

Crescina Transdermic Development Hfsc Man 500 Treatment Is A Specially Designed Male Composition For The Middle Stages Of Dilution And Is Available In A Pack Of 20 Vials (One Month Treatment) And In A Pack Of 40 Vials (Two Months Treatment).
The Vials Contain 3.5Ml Of Preparation.

The Patented Composition, Thanks To Labo Transdermal Technology, Allows The Active Molecules To Enter The Hair System Not Only Through The Hair Follicles But Also Transdermally, Ie Through The Layers Of The Scalp (Skin And Dermis). Thanks To Their Low Molecular Weight And The Presence Of 3 Absorption Enhancers, The Penetration And Performance Of The Functional Active Ingredients Is Facilitated. The Treatment Achieves Overall Action In All Hair Structures And Its Composition Enhances The Normal Growth Of Hair In Healthy And Semi-Active Follicles.

Effective In 100% Of Individuals Tested
Results After 4 Months In The In Vivo Clinical / Instrumental Double-Blind Randomized Trial, Controlled With Placebo In 46 People (Of Whom 23 Received Crescina Hfsc And The Remaining 23 Received Placebo). The Men Tested Had Grade Ii, Iii, Iii Vertex And Iv Dilutions On The Hamilton-Norwood Scale. Positive Results Were Recorded In All Individuals, Namely They Grew From +7 Minimum To +41 Maximum New Hairs In Electronically Measured Area 1,8 Cm². The Test Results Are Statistically Significant.
Growth Of 6.300 New Hairs On Average After 4 Months Of Treatment With Crescina Hfsc 100%.
Instrumental Analysis Performed With Phototrichogram.

Dermatologically Tested Composition.

Crescina Patents
• Swiss Patent Ch 703 390
• Swiss Patent Ch 711 466
• Swiss Patent Ch 697 229
• Swiss Patent Ch 693 815
• Swiss Patent Ch 693 814
• Swiss Patent Ch 693 816
• Swiss Patent Ch 704 629
• European Patent Ep 2 561 858